Table 3.
Outcome and intensive care treatment of patients without frailty (CFS < 5) and disability (ADL 6), patients with either disability (ADL < 6) or frailty (CFS ≥ 5), or both frailty and disability
| Non-frailty (CFS < 5)/no disability (ADL 6) | Frailty (CFS ≥ 5) or disability (ADL < 6) | Frailty and disability | p-value | |
|---|---|---|---|---|
| Invasive mechanical ventilation | 76% (1388) | 62% (162) | 68% (183) | < 0.001 |
| Non-invasive mechanical ventilation | 23% (414) | 29% (75) | 31% (84) | 0.002 |
| Tracheostomy | 21% (376) | 12% (31) | 10% (28) | < 0.001 |
| Vasoactive drugs | 72% (1312) | 58% (149) | 67% (178) | < 0.001 |
| RRT | 14% (255) | 16% (41) | 23% (61) | < 0.001 |
| Life sustaining care withheld | 30% (540) | 42% (106) | 31% (83) | < 0.001 |
| Life sustaining care withdrawn | 20% (369) | 21% (52) | 16% (44) | 0.32 |
| ICU mortality | 45% (810) | 55% (140) | 67% (180) | < 0.001 |
| 30-day mortality | 46% (848) | 63% (162) | 72% (195) | < 0.001 |
| 3-month mortality | 52% (945) | 68% (176) | 78% (210) | < 0.001 |
ADL Activities of Daily Living, CFS Clinical Frailty Scale, RRT renal replacement therapy, p-value comparing all groups. [Numbers do not add up to 100% due to missing values]